Literature DB >> 15618192

Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients.

Anna Lundgren1, Erika Strömberg, Asa Sjöling, Catharina Lindholm, Karin Enarsson, Anders Edebo, Erik Johnsson, Elisabeth Suri-Payer, Pia Larsson, Anna Rudin, Ann-Mari Svennerholm, B Samuel Lundin.   

Abstract

Helicobacter pylori chronically colonizes the stomach and duodenum and causes peptic ulcers or gastric adenocarcinoma in 10 to 20% of infected individuals. We hypothesize that the inability of patients to clear H. pylori infections is a consequence of active suppression of the immune response. Here we show that H. pylori-infected individuals have increased frequencies of CD4(+) CD25(high) T cells in both the stomach and duodenal mucosa compared to uninfected controls. These cells have the phenotype of regulatory T cells, as they express FOXP3, a key gene for the development and function of regulatory T cells, as well as high levels of the cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) protein. In contrast, mucosal CD4(+) CD25(low) and CD4(+) CD25(-) cells express little FOXP3 mRNA and low levels of the CTLA-4 protein. Mucosal CD4(+) CD25(high) T cells are present in individuals with asymptomatic H. pylori infections as well as in duodenal ulcer patients. The frequencies of CD4(+) CD25(high) cells are also increased in the stomachs of H. pylori-infected patients with gastric adenocarcinoma, particularly in cancer-affected tissues. These findings suggest that regulatory T cells may suppress mucosal immune responses and thereby contribute to the persistence of H. pylori infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618192      PMCID: PMC538965          DOI: 10.1128/IAI.73.1.523-531.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

2.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

Review 3.  Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases.

Authors:  Peter McGuirk; Kingston H G Mills
Journal:  Trends Immunol       Date:  2002-09       Impact factor: 16.687

4.  CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice.

Authors:  Shohei Hori; Thiago L Carvalho; Jocelyne Demengeot
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

5.  Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood.

Authors:  Kajsa Wing; Ann Ekmark; Helen Karlsson; Anna Rudin; Elisabeth Suri-Payer
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells.

Authors:  Kajsa Wing; Susanne Lindgren; Gittan Kollberg; Anna Lundgren; Robert A Harris; Anna Rudin; Samuel Lundin; Elisabeth Suri-Payer
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

8.  An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Authors:  Roli Khattri; Tom Cox; Sue-Ann Yasayko; Fred Ramsdell
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

9.  Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals.

Authors:  Anna Lundgren; Elisabeth Suri-Payer; Karin Enarsson; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.

Authors:  Udaya K Liyanage; Todd T Moore; Hong-Gu Joo; Yoshiyuki Tanaka; Virginia Herrmann; Gerard Doherty; Jeffrey A Drebin; Steven M Strasberg; Timothy J Eberlein; Peter S Goedegebuure; David C Linehan
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  108 in total

1.  Fucosylation and protein glycosylation create functional receptors for cholera toxin.

Authors:  Amberlyn M Wands; Akiko Fujita; Janet E McCombs; Jakob Cervin; Benjamin Dedic; Andrea C Rodriguez; Nicole Nischan; Michelle R Bond; Marcel Mettlen; David C Trudgian; Andrew Lemoff; Marianne Quiding-Järbrink; Bengt Gustavsson; Catharina Steentoft; Henrik Clausen; Hamid Mirzaei; Susann Teneberg; Ulf Yrlid; Jennifer J Kohler
Journal:  Elife       Date:  2015-10-29       Impact factor: 8.140

2.  Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa.

Authors:  Anna Lundgren; Christina Trollmo; Anders Edebo; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Regulatory T cells in human disease and their potential for therapeutic manipulation.

Authors:  Leonie S Taams; Donald B Palmer; Arne N Akbar; Douglas S Robinson; Zarin Brown; Catherine M Hawrylowicz
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 4.  Regulatory T cells in microbial infection.

Authors:  Jocelyne Demengeot; Santiago Zelenay; Maria Francisca Moraes-Fontes; Iris Caramalho; António Coutinho
Journal:  Springer Semin Immunopathol       Date:  2006-07-28

5.  Cooperation of Gastric Mononuclear Phagocytes with Helicobacter pylori during Colonization.

Authors:  Monica Viladomiu; Josep Bassaganya-Riera; Nuria Tubau-Juni; Barbara Kronsteiner; Andrew Leber; Casandra W Philipson; Victoria Zoccoli-Rodriguez; Raquel Hontecillas
Journal:  J Immunol       Date:  2017-03-06       Impact factor: 5.422

6.  Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.

Authors:  Damien Bresson; Lisa Togher; Evelyn Rodrigo; Yali Chen; Jeffrey A Bluestone; Kevan C Herold; Matthias von Herrath
Journal:  J Clin Invest       Date:  2006-04-20       Impact factor: 14.808

7.  H.pylori Infection Alleviates Acute and Chronic Colitis with the Expansion of Regulatory B Cells in Mice.

Authors:  Xia Li; Jiang Tan; Feng Zhang; Qian Xue; Ning Wang; Xu Cong; Jingtong Wang
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

8.  Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis.

Authors:  Núria Alonso; María Jesús Martínez-Arconada; María Luisa Granada; Berta Soldevila; Ana Cantón; José Luis Mate; Anna Sanmartí; Eva María Martínez-Cáceres
Journal:  Endocrine       Date:  2009-03-17       Impact factor: 3.633

9.  Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis.

Authors:  Vladislaw Muratov; Ann-Kristin Ulfgren; Marianne Engström; Kerstin Elvin; Ola Winqvist; Robert Löfberg; Joachim Lundahl
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

10.  Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo.

Authors:  Dana M Bronte-Tinkew; Mauricio Terebiznik; Aime Franco; Michelle Ang; Diane Ahn; Hitomi Mimuro; Chihiro Sasakawa; Mark J Ropeleski; Richard M Peek; Nicola L Jones
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.